Hotter CPI Hits Stocks, but Big Pharma Defies the Slide
Eli Lilly, Merck, AbbVie, and UnitedHealth rose as markets fell on stronger inflation data, highlighting healthcare’s defensive strength.
Eli Lilly, Merck, AbbVie, and UnitedHealth rose as markets fell on stronger inflation data, highlighting healthcare’s defensive strength.
UnitedHealth raised its 2026 EPS forecast to at least $20.50 after adjusted Q3 earnings of $4.69 beat estimates, helped by improved medical cost controls.
Humana rose after its main plan regained 4 stars; Alignment fell as its biggest plan dropped to 3.5.
Strong cost control and Optum performance drive recovery.
UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.
Bank of America upgraded UNH to Buy, raising target to $450 as lower healthcare costs boost earnings outlook.